Merck KGaA (OTCMKTS:MKGAF) Shares Gap Down – Here’s What Happened
by Amy Steele · The Cerbat GemMerck KGaA (OTCMKTS:MKGAF – Get Free Report) gapped down prior to trading on Tuesday. The stock had previously closed at $159.4510, but opened at $152.6740. Merck KGaA shares last traded at $162.5340, with a volume of 2,695 shares.
Merck KGaA Price Performance
The company has a debt-to-equity ratio of 0.27, a quick ratio of 0.84 and a current ratio of 1.31. The business has a 50-day simple moving average of $160.89 and a 200 day simple moving average of $150.47. The firm has a market cap of $21.01 billion, a P/E ratio of 24.81 and a beta of 0.96.
Institutional Trading of Merck KGaA
Several large investors have recently bought and sold shares of the company. Elefante Mark B bought a new position in shares of Merck KGaA in the second quarter worth approximately $617,000. Ames National Corp bought a new stake in shares of Merck KGaA during the second quarter valued at approximately $1,009,000. Notis McConarty Edward purchased a new position in Merck KGaA in the 2nd quarter worth approximately $1,304,000. North Star Asset Management Inc. purchased a new position in Merck KGaA in the 2nd quarter worth approximately $1,411,000. Finally, Pinnacle Holdings LLC bought a new position in Merck KGaA in the 2nd quarter valued at approximately $1,487,000. 0.10% of the stock is owned by institutional investors.
About Merck KGaA
Merck KGaA is a Germany-based science and technology company headquartered in Darmstadt. Founded in 1668, it is one of the world’s oldest operating pharmaceutical and chemical companies. Merck KGaA is separate from the U.S.-based Merck & Co, Inc, although the two companies share historical roots.
The company operates through three business sectors: Life Science, Healthcare and Electronics. Its Life Science business supplies laboratory products, research tools, chemicals and bioprocessing technologies used by pharmaceutical, biotechnology and academic customers.